2014
DOI: 10.1016/j.nrleng.2013.07.002
|View full text |Cite
|
Sign up to set email alerts
|

Intravenous thrombolysis with recombinant tissue plasminogen activator in vascular warning syndromes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 21 publications
0
4
0
Order By: Relevance
“…Thus, it seems that the appropriateness of the term ‘Capsular Warning Syndrome’ should be reconsidered. Perhaps ‘Vascular Warning Syndrome’ or ‘Stroke Warning Syndrome’, terms used in recent studies, may be more appropriate as CWS can occur from a lesion anywhere in the corticospinal tract (4,6).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, it seems that the appropriateness of the term ‘Capsular Warning Syndrome’ should be reconsidered. Perhaps ‘Vascular Warning Syndrome’ or ‘Stroke Warning Syndrome’, terms used in recent studies, may be more appropriate as CWS can occur from a lesion anywhere in the corticospinal tract (4,6).…”
Section: Discussionmentioning
confidence: 99%
“…Thus, several aspects regarding the clinical management of these patients remain controversial. Additionally, whether the outcome of CWS is modified by thrombolysis is uncertain, and few studies have reported the short-term clinical outcomes of these patients who were treated with recombinant tissue plasminogen activator (rtPA) (4,6). Finally, there are no reports regarding long-term stroke and other vascular recurrences in CWS patients.…”
Section: Introductionmentioning
confidence: 99%
“…A recent study showed that infarct locations of CWS vary; 50% of CWS patients have infarctions in the internal capsule, but the other half have infarctions in other locations ( 14 ). As such, some researchers and clinicians have suggested that the term “capsular warning syndrome” might not be adequate, and “vascular warning syndrome” or “stroke warning syndrome” has been used in some recent reports ( 8 , 14 , 15 ). Our patient had recurrent stereotyped episodes of TIAs, and MRI showed acute cerebral infarctions in the internal capsule to corona radiata, so we diagnosed her with CWS.…”
Section: Discussionmentioning
confidence: 99%
“…About 40% to 60% of CWS patients develop a cerebral infarction within 10 days ( 1 , 2 ). Many different treatments have been proposed, such as multi-target antiplatelet therapies ( 3 - 6 ), a loading dose of clopidogrel ( 4 , 5 ), and recombinant tissue plasminogen activator (rt-PA) ( 7 - 15 ), but no effective therapy has yet been established. In addition, the efficacy of rt-PA on the outcome of CWS has not been determined.…”
Section: Introductionmentioning
confidence: 99%